Form 8-K - Current report:
SEC Accession No. 0001493152-25-010211
Filing Date
2025-03-13
Accepted
2025-03-13 16:19:01
Documents
16
Period of Report
2025-03-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 53298
2 ex1-1.htm EX-1.1 341957
3 ex99-1.htm EX-99.1 13430
4 ex99-2.htm EX-99.2 15288
  Complete submission text file 0001493152-25-010211.txt   683357

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE shph-20250312.xsd EX-101.SCH 3030
6 XBRL LABEL FILE shph-20250312_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE shph-20250312_pre.xml EX-101.PRE 22369
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3817
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41488 | Film No.: 25736042
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)